Skip to content

The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination

The Effect of Health Belief Model-Based Education on Mothers of Children Aged 9-15 Years: Impact on HPV Knowledge Level and Child Vaccination

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07450703
Enrollment
100
Registered
2026-03-05
Start date
2026-04-01
Completion date
2026-12-01
Last updated
2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer , Healthy, Health Belief Model, HPV - Anogenital Human Papilloma Virus Infection

Keywords

HUMAN PAPİLLOMA VIRUS, WOMEN HEALTH, VACCINE EDUCATİON

Brief summary

This study aims to examine the effects of education provided to mothers of children aged 9-15 within the framework of the Health Belief Model on mothers' knowledge, attitudes, and behaviors about Human Papillomavirus (HPV), and their willingness to have their children vaccinated against HPV. The study, designed with a randomized controlled experimental design, will be conducted at three different Family Health Centers in Gaziantep and will consist of both experimental and control groups. Mothers in the experimental group will receive a three-session visually supported education program prepared by Yıldız USCA, while the control group will receive routine information using HPV brochures from the Ministry of Health. Data collection tools include a personal information form, an HPV knowledge scale, and an HPV Health Belief Model scale.

Interventions

BEHAVIORALHEALTH BELİEF MODEL

In social psychology, the health belief model (HBM) is a psychological framework used to explain and predict individuals' potentially detrimental behaviors, attitudes and beliefs on their health. Developed in the 1950s by social psychologists at the United States Public Health Service, the model examines how perceptions of susceptibility to illness, the severity of health conditions, the benefits of preventive care, and barriers to healthcare influence behavior. The HBM is widely used in health behavior research and public health interventions to understand and promote engagement in health-protective behaviors

Sponsors

University of Gaziantep
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Literate and able to understand and speak Turkish * Mother of a child aged 9-15 years * Did not receive any HPV-related education in the past 6 months * Has not had HPV vaccination previously * Willing to participate voluntarily

Exclusion criteria

* Presence of serious physical or cognitive impairment preventing participation * Refusal to provide informed consent * Already vaccinated against HPV * Already received HPV-related education within the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Change in HPV Knowledge Score1 month after the education programHealth Belief Model Scale(HPVA-SIM): The scale consists of 14 items and four sub-dimensions: perceived benefit (Items 1-3), perceived sensitivity (Items 4-5), perceived seriousness (Items 6-9), and perceived barrier (Items 10-14). The Cronbach Alpha reliability coefficient was calculated as .78 for perceived benefit, .72 for perceived sensitivity, .78 for perceived severity, and .71 for perceived barrier in the sub-dimensions of the scale http://dx.doi.org/10.1016 HPV Knowledge Scale (HPV-KÖ): The HPV-KÖ includes three sub-dimensions of 29 items.Factor 1: General HPV knowledge, Factor 2: Knowledge of HPV screening tests, Factor 3: General HPV vaccine knowledge, Factor 4: Knowledge of the current HPV vaccination program. The Cronbach α value for the 29 items of the original scale was reported as 0.83, and the consistency of the scale was reported to be high for this value doi.org/10.4274/jtgga.galenos.2023.2022-10-9

Contacts

CONTACTYILDIZ USCA
yildizusca@gmail.com05066736770
CONTACTHATİCE SERAP KOÇAK
stasdemirmeister@gmail.com5325920089

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026